SPTBN1 encodes βII-spectrin, the ubiquitously expressed β-spectrin that forms micrometer-scale networks associated with plasma membranes. Mice deficient in neuronal βII-spectrin have defects in cortical organization, developmental delay and behavioral deficiencies. These phenotypes, while less severe, are observed in haploinsufficient animals, suggesting that individuals carrying heterozygous SPTBN1 variants may also show measurable compromise of neural development and function. Here we identify heterozygous SPTBN1 variants in 29 individuals with developmental, language and motor delays; mild to severe intellectual disability; autistic features; seizures; behavioral and movement abnormalities; hypotonia; and variable dysmorphic facial features. We show that these SPTBN1 variants lead to effects that affect βII-spectrin stability, disrupt binding to key molecular partners, and disturb cytoskeleton organization and dynamics. Our studies define SPTBN1 variants as the genetic basis of a neurodevelopmental syndrome, expand the set of spectrinopathies affecting the brain and underscore the critical role of βII-spectrin in the central nervous system.

• MeSH
• dominantní geny * MeSH
• fenotyp MeSH
• genetická predispozice k nemoci * MeSH
• genetická variace * MeSH
• genetické asociační studie metody   MeSH
• heterozygot MeSH
• lidé MeSH
• myši MeSH
• neurovývojové poruchy diagnóza   genetika   MeSH
• spektrin genetika   metabolismus   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Názvy látek
• spektrin MeSH
• SPTBN1 protein, human MeSH Prohlížeč

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of cortical, brain stem and spinal motor neurons that leads to muscle weakness and death. A previous study implicated CACNA1H encoding for Cav3.2 calcium channels as a susceptibility gene in ALS. In the present study, two heterozygous CACNA1H variants were identified by whole genome sequencing in a small cohort of ALS patients. These variants were functionally characterized using patch clamp electrophysiology, biochemistry assays, and molecular modeling. A previously unreported c.454GTAC > G variant produced an inframe deletion of a highly conserved isoleucine residue in Cav3.2 (p.ΔI153) and caused a complete loss-of-function of the channel, with an additional dominant-negative effect on the wild-type channel when expressed in trans. In contrast, the c.3629C > T variant caused a missense substitution of a proline with a leucine (p.P1210L) and produced a comparatively mild alteration of Cav3.2 channel activity. The newly identified ΔI153 variant is the first to be reported to cause a complete loss of Cav3.2 channel function. These findings add to the notion that loss-of-function of Cav3.2 channels associated with rare CACNA1H variants may be risk factors in the complex etiology of ALS.

• Klíčová slova
• ALS, Amyotrophic lateral sclerosis, Biophysics, CACNA1H, Calcium channel, Cav3.2 channel, Motor neuron disease, Mutation, T-type channel,
• MeSH
• amyotrofická laterální skleróza * genetika   MeSH
• dominantní geny MeSH
• genetická predispozice k nemoci * MeSH
• genetické asociační studie * MeSH
• heterozygot MeSH
• krysa rodu Rattus MeSH
• lidé MeSH
• mutace * genetika   MeSH
• sekvence aminokyselin MeSH
• sekvenování celého genomu MeSH
• strukturní homologie proteinů MeSH
• vápníkové kanály - typ T * chemie   genetika   MeSH
• zvířata MeSH
• Check Tag
• krysa rodu Rattus MeSH
• lidé MeSH
• mužské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• CACNA1H protein, human MeSH Prohlížeč
• vápníkové kanály - typ T * MeSH

Introduction: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic cause of renal impairment resulting from mutations in the MUC1, UMOD, HNF1B, REN, and SEC61A1 genes. Neither the national or global prevalence of these diseases has been determined. We aimed to establish a database of patients with ADTKD in Ireland and report the clinical and genetic characteristics of these families. Methods: We identified patients via the Irish Kidney Gene Project and referral to the national renal genetics clinic in Beaumont Hospital who met the clinical criteria for ADTKD (chronic kidney disease, bland urinary sediment, and autosomal dominant inheritance). Eligible patients were then invited to undergo genetic testing by a variety of methods including panel-based testing, whole exome sequencing and, in five families who met the criteria for diagnosis of ADTKD but were negative for causal genetic mutations, we analyzed urinary cell smears for the presence of MUC1fs protein. Results: We studied 54 individuals from 16 families. We identified mutations in the MUC1 gene in three families, UMOD in five families, HNF1beta in two families, and the presence of abnormal MUC1 protein in urine smears in three families (one of which was previously known to carry the genetic mutation). We were unable to identify a mutation in 4 families (3 of whom also tested negative for urinary MUC1fs). Conclusions: There are 4443 people with ESRD in Ireland, 24 of whom are members of the cohort described herein. We observe that ADTKD represents at least 0.54% of Irish ESRD patients.

• Klíčová slova
• ADTKD, HNF-1B, MUC-1, UMOD, chronic kidney disease, frameshift, genetic, urinary smear,
• MeSH
• chronické selhání ledvin epidemiologie   genetika   patologie   MeSH
• dominantní geny * MeSH
• dospělí MeSH
• genetické testování statistika a číselné údaje   MeSH
• hepatocytární jaderný faktor 1-beta genetika   MeSH
• ledvinové kanálky patologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mucin 1 genetika   MeSH
• mutace MeSH
• prevalence MeSH
• průřezové studie MeSH
• senioři MeSH
• uromodulin genetika   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• Geografické názvy
• Irsko epidemiologie   MeSH
• Názvy látek
• hepatocytární jaderný faktor 1-beta MeSH
• HNF1B protein, human MeSH Prohlížeč
• MUC1 protein, human MeSH Prohlížeč
• mucin 1 MeSH
• UMOD protein, human MeSH Prohlížeč
• uromodulin MeSH

Although mutations in more than 90 genes are known to cause CMT, the underlying genetic cause of CMT remains unknown in more than 50% of affected individuals. The discovery of additional genes that harbor CMT2-causing mutations increasingly depends on sharing sequence data on a global level. In this way-by combining data from seven countries on four continents-we were able to define mutations in ATP1A1, which encodes the alpha1 subunit of the Na+,K+-ATPase, as a cause of autosomal-dominant CMT2. Seven missense changes were identified that segregated within individual pedigrees: c.143T>G (p.Leu48Arg), c.1775T>C (p.Ile592Thr), c.1789G>A (p.Ala597Thr), c.1801_1802delinsTT (p.Asp601Phe), c.1798C>G (p.Pro600Ala), c.1798C>A (p.Pro600Thr), and c.2432A>C (p.Asp811Ala). Immunostaining peripheral nerve axons localized ATP1A1 to the axolemma of myelinated sensory and motor axons and to Schmidt-Lanterman incisures of myelin sheaths. Two-electrode voltage clamp measurements on Xenopus oocytes demonstrated significant reduction in Na+ current activity in some, but not all, ouabain-insensitive ATP1A1 mutants, suggesting a loss-of-function defect of the Na+,K+ pump. Five mutants fall into a remarkably narrow motif within the helical linker region that couples the nucleotide-binding and phosphorylation domains. These findings identify a CMT pathway and a potential target for therapy development in degenerative diseases of peripheral nerve axons.

• Klíčová slova
• ATP1A1, CMT, Charcot-Marie-Tooth, Mendelian disease, Na(+),K(+) ATPase, axonal neuropathy, genetic matchmaking,
• MeSH
• Charcotova-Marieova-Toothova nemoc genetika   MeSH
• dítě MeSH
• dominantní geny * MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mutace genetika   MeSH
• rodina MeSH
• rodokmen MeSH
• sekvence aminokyselin MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• sodíko-draslíková ATPasa chemie   genetika   MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Názvy látek
• ATP1A1 protein, human MeSH Prohlížeč
• sodíko-draslíková ATPasa MeSH

Mutation of SMARCA4 (BRG1), the ATPase of BAF (mSWI/SNF) and PBAF complexes, contributes to a range of malignancies and neurologic disorders. Unfortunately, the effects of SMARCA4 missense mutations have remained uncertain. Here we show that SMARCA4 cancer missense mutations target conserved ATPase surfaces and disrupt the mechanochemical cycle of remodeling. We find that heterozygous expression of mutants alters the open chromatin landscape at thousands of sites across the genome. Loss of DNA accessibility does not directly overlap with Polycomb accumulation, but is enriched in 'A compartments' at active enhancers, which lose H3K27ac but not H3K4me1. Affected positions include hundreds of sites identified as superenhancers in many tissues. Dominant-negative mutation induces pro-oncogenic expression changes, including increased expression of Myc and its target genes. Together, our data suggest that disruption of enhancer accessibility represents a key source of altered function in disorders with SMARCA4 mutations in a wide variety of tissues.

• MeSH
• adenosintrifosfatasy metabolismus   MeSH
• chromatin chemie   MeSH
• DNA-helikasy genetika   MeSH
• dominantní geny * MeSH
• epigenomika MeSH
• genotyp MeSH
• heterozygot MeSH
• jaderné proteiny genetika   MeSH
• kultivační média MeSH
• lidé MeSH
• missense mutace MeSH
• multivariační analýza MeSH
• mutace * MeSH
• myší embryonální kmenové buňky cytologie   MeSH
• myši transgenní MeSH
• myši MeSH
• nádory genetika   MeSH
• polycomb proteiny genetika   MeSH
• restrukturace chromatinu MeSH
• sekvenční analýza RNA MeSH
• transkripční faktory genetika   MeSH
• zesilovače transkripce MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Názvy látek
• adenosintrifosfatasy MeSH
• chromatin MeSH
• DNA-helikasy MeSH
• jaderné proteiny MeSH
• kultivační média MeSH
• polycomb proteiny MeSH
• SMARCA4 protein, human MeSH Prohlížeč
• transkripční faktory MeSH

A bilaterally blind woman, with a three generation family history of autosomal dominant congenital cataracts, variably associated with iris colobomata and microcornea, sought preconception genetic consultation. Whole-exome sequencing was performed in three affected family members, one unaffected first degree relative, and one spouse. The sequence variant c.168C>G; p.(Tyr56∗) in CRYGD, previously reported as pathogenic, and a novel mutation c.809C>A; p.(Ser270Tyr) in MAF, were identified in two affected family members; the grandmother, and half-brother of the proband. The proband inherited only the MAF mutation, whereas her clinically unaffected sister had the CRYGD change. In silico analysis supported a pathogenic role of p.(Ser270Tyr) in MAF, which was absent from publicly available whole-exome datasets, and 1161 Czech individuals. The frequency of CRYGD p.(Tyr56∗) in the ExAC dataset was higher than the estimated incidence of congenital cataract in the general population. Our study highlights that patients with genetically heterogeneous conditions may exhibit rare variants in more than one disease-associated gene, warranting caution with data interpretation, and supporting parallel screening of all genes known to harbour pathogenic mutations for a given phenotype. The pathogenicity of sequence variants previously reported as cataract-causing may require re-assessment in light of recently released datasets of human genomic variation.

• Klíčová slova
• CRYGD, Coloboma, Congenital cataract, MAF, Microcornea,
• MeSH
• dominantní geny genetika   MeSH
• dospělí MeSH
• exom genetika   MeSH
• fenotyp MeSH
• gama-krystaliny genetika   metabolismus   MeSH
• katarakta vrozené   genetika   MeSH
• lidé MeSH
• mutace genetika   MeSH
• mutační analýza DNA metody   MeSH
• protoonkogenní proteiny c-maf genetika   metabolismus   MeSH
• rodokmen MeSH
• sekvenování exomu metody   MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• kazuistiky MeSH
• Názvy látek
• CRYGD protein, human MeSH Prohlížeč
• gama-krystaliny MeSH
• MAF protein, human MeSH Prohlížeč
• protoonkogenní proteiny c-maf MeSH

Autosomal-dominant tubulo-interstitial kidney disease (ADTKD) encompasses a group of disorders characterized by renal tubular and interstitial abnormalities, leading to slow progressive loss of kidney function requiring dialysis and kidney transplantation. Mutations in UMOD, MUC1, and REN are responsible for many, but not all, cases of ADTKD. We report on two families with ADTKD and congenital anemia accompanied by either intrauterine growth retardation or neutropenia. Ultrasound and kidney biopsy revealed small dysplastic kidneys with cysts and tubular atrophy with secondary glomerular sclerosis, respectively. Exclusion of known ADTKD genes coupled with linkage analysis, whole-exome sequencing, and targeted re-sequencing identified heterozygous missense variants in SEC61A1-c.553A>G (p.Thr185Ala) and c.200T>G (p.Val67Gly)-both affecting functionally important and conserved residues in SEC61. Both transiently expressed SEC6A1A variants are delocalized to the Golgi, a finding confirmed in a renal biopsy from an affected individual. Suppression or CRISPR-mediated deletions of sec61al2 in zebrafish embryos induced convolution defects of the pronephric tubules but not the pronephric ducts, consistent with the tubular atrophy observed in the affected individuals. Human mRNA encoding either of the two pathogenic alleles failed to rescue this phenotype as opposed to a complete rescue by human wild-type mRNA. Taken together, these findings provide a mechanism by which mutations in SEC61A1 lead to an autosomal-dominant syndromic form of progressive chronic kidney disease. We highlight protein translocation defects across the endoplasmic reticulum membrane, the principal role of the SEC61 complex, as a contributory pathogenic mechanism for ADTKD.

• MeSH
• alely MeSH
• anemie genetika   MeSH
• biopsie MeSH
• chronická nemoc MeSH
• dánio pruhované embryologie   genetika   MeSH
• dítě MeSH
• dominantní geny MeSH
• dospělí MeSH
• endoplazmatické retikulum metabolismus   MeSH
• exom genetika   MeSH
• fenotyp MeSH
• Golgiho aparát metabolismus   MeSH
• heterozygot * MeSH
• lidé středního věku MeSH
• lidé MeSH
• messenger RNA analýza   genetika   MeSH
• missense mutace genetika   MeSH
• mladý dospělý MeSH
• molekulární modely MeSH
• mutace * MeSH
• nemoci ledvin genetika   patologie   MeSH
• neutropenie genetika   MeSH
• novorozenec MeSH
• progrese nemoci MeSH
• rodokmen MeSH
• růstová retardace plodu genetika   MeSH
• sekvence aminokyselin MeSH
• senioři MeSH
• syndrom MeSH
• translokační kanály SEC chemie   genetika   MeSH
• zvířata MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• novorozenec MeSH
• senioři MeSH
• ženské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• kazuistiky MeSH
• Názvy látek
• messenger RNA MeSH
• SEC61A1 protein, human MeSH Prohlížeč
• translokační kanály SEC MeSH

OBJECTIVE: Autosomal dominant hypocalcemia (ADH) is a rare disorder caused by activating mutations of the calcium-sensing receptor (CASR). The treatment of ADH patients with 1α-hydroxylated vitamin D derivatives can cause hypercalciuria leading to nephrocalcinosis. DESIGN AND METHODS: We studied a girl who presented with hypoparathyroidism and asymptomatic hypocalcemia at age 2.5 years. Mutations of CASR were investigated by DNA sequencing. Functional analyses of mutant and WT CASRs were done in transiently transfected human embryonic kidney (HEK293) cells. RESULTS: The proband and her father are heterozygous for an eight-nucleotide deletion c.2703_2710delCCTTGGAG in the CASR encoding the intracellular domain of the protein. Transient expression of CASR constructs in kidney cells in vitro suggested greater cell surface expression of the mutant receptor with a left-shifted extracellular calcium dose-response curve relative to that of the WT receptor consistent with gain of function. Initial treatment of the patient with calcitriol led to increased urinary calcium excretion. Evaluation for mosaicism in the paternal grandparents of the proband was negative. CONCLUSIONS: We describe a novel naturally occurring deletion mutation within the CASR that apparently arose de novo in the father of the ADH proband. Functional analysis suggests that the cytoplasmic tail of the CASR contains determinants that regulate the attenuation of signal transduction. Early molecular analysis of the CASR gene in patients with isolated idiopathic hypoparathyroidism is recommended because of its relevance to clinical outcome and treatment choice. In ADH patients, calcium supplementation and low-dose cholecalciferol avoids hypocalcemic symptoms without compromising renal function.

• MeSH
• cytoplazma MeSH
• dominantní geny * MeSH
• dospělí MeSH
• HEK293 buňky MeSH
• heterozygot MeSH
• hyperkalciurie genetika   patologie   MeSH
• hypokalcemie genetika   patologie   MeSH
• hypoparatyreóza vrozené   genetika   patologie   MeSH
• lidé MeSH
• nesmyslný kodon genetika   MeSH
• předškolní dítě MeSH
• receptory "calcium-sensing" chemie   genetika   MeSH
• rodina MeSH
• rodokmen MeSH
• sekvence nukleotidů MeSH
• sekvenční delece * MeSH
• terciární struktura proteinů genetika   MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• kazuistiky MeSH
• práce podpořená grantem MeSH
• Názvy látek
• nesmyslný kodon MeSH
• receptory "calcium-sensing" MeSH

UNLABELLED: Tuberous sclerosis is a disease with an autosomal dominant pattern of inheritance which is characterized by the development of benign tumours in many tissues and organs. Clinical signs are extremely variable, causing mutations in the gene TSC1 or TSC2. Complex formed by the products of the TSC genes regulates cell growth and proliferation by inhibition of mTORC1 signalling. Early diagnosis of TSC is very important to plan appropriate perinatal care. Using ultrasound and eventually MRI it is possible in the prenatal period to capture the following major features of tuberous sclerosis: cardiac rhabdomyo-ma, subependymal nodules, cortical tubers and renal angiomyolipomas. In connection with the syndrome of contiguous genes TSC2 / PKD1 can also be detect foetal renal cysts. Often these TSC-associated lesions represent an incidental finding during a routine ultrasound. In the period from the 20th week of pregnancy it is most often found cardiac rhabdomyoma/s as the first marker suggestive of tuberous sclerosis. In the case, where one of the parents is a carrier of already identified mutation in the TSC gene, it is possible to carry out targeted genetic testing of a sample of DNA isolated from cells of chorionic villi, amniocytes or tissue from aborted foe-tuses. Significantly more time consuming is to perform molecular analysis of the TSC genes in foetuses with suspected tuberous sclerosis without the occurrence of illness in the family. After finding a causal mutation and its confirmation, it is possible to offer genetic testing for other persons at risk, prenatal (eventually preimplantation) diagnosis for future pregnancies. It is also necessary to consider the possibility of gonadal mosaicism. DESIGN: Review of the literature.

• Klíčová slova
• TSC1, TSC2, foetal rhabdomyoma, mosaicism., sequencing, tuberous sclerosis complex,
• MeSH
• chromozomální aberace MeSH
• detekce genetických nosičů MeSH
• dominantní geny genetika   MeSH
• genetické testování MeSH
• hamartin MeSH
• lidé MeSH
• mozaicismus MeSH
• mutační analýza DNA MeSH
• nádorové supresorové proteiny genetika   MeSH
• náhodný nález MeSH
• odběr choriových klků MeSH
• prenatální péče * MeSH
• těhotenství MeSH
• tuberin MeSH
• tuberózní skleróza diagnóza   genetika   MeSH
• ultrasonografie prenatální MeSH
• ultrasonografie MeSH
• Check Tag
• lidé MeSH
• těhotenství MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• hamartin MeSH
• nádorové supresorové proteiny MeSH
• TSC1 protein, human MeSH Prohlížeč
• TSC2 protein, human MeSH Prohlížeč
• tuberin MeSH

Cell cycle control must be modified at meiosis to allow two divisions to follow a single round of DNA replication, resulting in ploidy reduction. The mechanisms that ensure meiosis termination at the end of the second and not at the end of first division are poorly understood. We show here that Arabidopsis thaliana TDM1, which has been previously shown to be essential for meiotic termination, interacts directly with the Anaphase-Promoting Complex. Further, mutations in TDM1 in a conserved putative Cyclin-Dependant Kinase (CDK) phosphorylation site (T16-P17) dominantly provoked premature meiosis termination after the first division, and the production of diploid spores and gametes. The CDKA;1-CYCA1.2/TAM complex, which is required to prevent premature meiotic exit, phosphorylated TDM1 at T16 in vitro. Finally, while CYCA1;2/TAM was previously shown to be expressed only at meiosis I, TDM1 is present throughout meiosis. These data, together with epistasis analysis, lead us to propose that TDM1 is an APC/C component whose function is to ensure meiosis termination at the end of meiosis II, and whose activity is inhibited at meiosis I by CDKA;1-TAM-mediated phosphorylation to prevent premature meiotic exit. This provides a molecular mechanism for the differential decision of performing an additional round of division, or not, at the end of meiosis I and II, respectively.

• MeSH
• anafázi podporující komplex metabolismus   MeSH
• Arabidopsis cytologie   genetika   MeSH
• biologické modely MeSH
• chromozomy rostlin genetika   MeSH
• cykliny genetika   metabolismus   MeSH
• dominantní geny MeSH
• fosforylace MeSH
• fosfothreonin metabolismus   MeSH
• genetická epistáze MeSH
• genetické testování MeSH
• meióza * MeSH
• mutace genetika   MeSH
• podjednotky proteinů metabolismus   MeSH
• proteiny huseníčku genetika   metabolismus   MeSH
• tetraploidie MeSH
• tubulin metabolismus   MeSH
• vazba proteinů MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• anafázi podporující komplex MeSH
• cykliny MeSH
• fosfothreonin MeSH
• podjednotky proteinů MeSH
• proteiny huseníčku MeSH
• TDM1 protein, Arabidopsis MeSH Prohlížeč
• tubulin MeSH